Avantor, Inc. (NYSE:AVTR) Shares Acquired by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC raised its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 917.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 20,700 shares of the company's stock after buying an additional 18,665 shares during the period. Nisa Investment Advisors LLC's holdings in Avantor were worth $436,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB boosted its stake in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock valued at $26,000 after acquiring an additional 625 shares during the last quarter. UMB Bank n.a. acquired a new stake in shares of Avantor in the 3rd quarter valued at about $49,000. GAMMA Investing LLC lifted its position in shares of Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock worth $70,000 after purchasing an additional 1,285 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt grew its stake in Avantor by 278.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company's stock worth $130,000 after purchasing an additional 3,700 shares in the last quarter. Finally, Quarry LP increased its holdings in Avantor by 4,489.1% in the second quarter. Quarry LP now owns 6,333 shares of the company's stock valued at $134,000 after buying an additional 6,195 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Stock Performance

Shares of AVTR traded up $0.73 during mid-day trading on Thursday, reaching $22.22. 3,606,373 shares of the company's stock traded hands, compared to its average volume of 4,784,199. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The business's 50-day moving average price is $21.63 and its 200-day moving average price is $23.43. The stock has a market capitalization of $15.12 billion, a P/E ratio of 48.29, a price-to-earnings-growth ratio of 3.53 and a beta of 1.28. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00.

Wall Street Analyst Weigh In

A number of research analysts have commented on AVTR shares. UBS Group reaffirmed a "neutral" rating and set a $25.00 target price (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Raymond James reduced their price objective on Avantor from $29.00 to $26.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 21st. Barclays lowered their target price on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research note on Friday, October 25th. Wells Fargo & Company reduced their price target on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Finally, Robert W. Baird lowered their price objective on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research report on Monday, October 28th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $27.38.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.